Subscribe To
89bio presents new analysis of data from phase 2 entrigue trial of pegozafermin in patients with severe hypertriglyceridemia (shtg) at american college of cardiology’s annual scientific session togeth
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG ...
March 4, 2023, 6:30 pm
89bio presents new analysis of data from phase 2 entrigue trial of pegozafermin in patients with severe hypertriglyceridemia (shtg) at american college of cardiology’s annual scientific session togeth
– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG ...
March 4, 2023, 6:30 pm
Uk says ukraine forces under increasingly severe pressure defending bakhmut
KYIV (Reuters) -Ukrainian forces defending Bakhmut are facing increasingly strong pressure from Russian forces, British military intelligence said on ...
March 4, 2023, 9:51 am
Director/cinematographer xiang cao presents as a judge at nft contest inspired by mixed martial artist jingliang li
As the contest’s judge, Xiang, who is known for his exceptional work in the film and music video industry, including his numerous award-winning musi...
March 3, 2023, 8:09 pm
Why is veru (veru) stock down 37% today?
Veru (NASDAQ: VERU ) stock is taking a beating on Friday after the FDA denied the company's request for EUA for its Covid-19 treatment. That rejection...
March 3, 2023, 9:23 am
Intellia's stock jumps as crispr therapy moves into phase 2 clinical trial
Shares of Intellia Therapeutics Inc. NTLA, +1.44% rallied about 10% in premarket trading on Thursday after the company said the Food and Drug Administ...
March 2, 2023, 8:09 am
Poolbeg pharma hails flu asset as a potential blockbuster after encouraging results
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) described its lead asset as a potential ‘blockbuster' after it announced promising results from its bacte...
March 2, 2023, 2:39 am
Only one of deutsche bank's 3 reasons to be bullish euro is performing well
Deutsche Bank's 3 "pillars' of their bullish EUR view are (in brief):
- EUR growth is turning back up, ECB terminal rate pricing continues...
March 2, 2023, 2:21 am
Japanese yen flatlines despite us dollar weakness. will treasury yields lift usd/jpy?
The Japanese Yen has steadied to start the week while the US Dollar has slipped as monetary policy disparity between the BoJ and the Fed perseveres. H...
March 2, 2023, 2:00 am
Euro traders lock gaze on eurozone inflation data
With economic data suggesting that the Euro area may have dodged a severe recession and underlying infl...
March 1, 2023, 11:07 am
Rallybio to present at upcoming investor conferences in march
NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerati...
March 1, 2023, 8:00 am
Canadian overseas petroleum production hit by bitter us weather
Canadian Overseas Petroleum has been granted a covenant waiver after severe weather in Wyoming affected...
March 1, 2023, 2:42 am
Eurgbp returns to february’s low; caution remains
EURGBP pulled below its 50-day simple moving average (SMA) at 0.8820, following encouraging headlines that the UK and the EU have found a new deal to ...
February 28, 2023, 10:05 am
Ecb vujcic: we should persevere if core inflation persists
ECB Governing Council member Boris Vujcic told Bloomberg TV yesterday, “as long as core (inflation) persists at the levels we’re talking about and...
February 28, 2023, 4:02 am
Argenx to present at upcoming investor conferences
February 2 7 , 202 3 Amsterdam , the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of...
February 27, 2023, 1:00 am
Why is nektar therapeutics (nktr) stock down 39% today?
Nektar Therapeutics (NASDAQ: NKTR ) stock is taking a beating on Friday following the release of Phase 2 clinical trial data. This Phase 2 study had N...
February 24, 2023, 8:56 am
Nektar stock drops more than 30% after study involving lupus treatment will not go forward
Shares of Nektar Therapeutics NKTR, -1.66% plunged more than 30% in the extended session Thursday after the biopharma company reported that a study di...
February 23, 2023, 5:24 pm
Alibaba beats expectations and that was before china lifted 'zero covid' restrictions
Alibaba Group (NYSE:BABA) easily topped fiscal third-quarter expectations on the top and bottom lines, but investors may already pricing in a banner f...
February 23, 2023, 11:53 am
Argenx to report full year 2022 financial results and fourth quarter business update on march 2, 2023
February 23 , 202 3 Amsterdam , the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of ...
February 23, 2023, 1:00 am
These 2 ultra-high-yield dividend stocks are severely underrated
These companies don't get enough credit for their big-time payouts....
February 22, 2023, 7:38 am
